Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  methyl-5-aminolevulinate hydrochloride cream
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Treating Actinic Keratoses With Natural Daylight PDT: Comparing Two Light Sensitizers (ALA and MAL)
Phase: Phase IV
Type: Health services research, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: R13073 / Q257, 2013-002108-15, NCT01893203
Phase III Randomized Study of Photodynamic Therapy With Methyl-5-aminolevulinate in Patients With Primary Nodular Basal Cell Carcinoma of the Skin
Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: RPCI-DS-0025, PC-T307/00, NCI-G01-2003, NCT00472108
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RD.03.SPR.29102, NCT01475071
Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RD.03.SPR.29112, NCT01821391
A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PC CE101/06, NCT00369018
Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 175410, NCI-2010-02319, NCT01292668
Start Over